VR Adviser, LLC Q1 2023 Filing
Filed May 15, 2023
Portfolio Value
$512.2T
Holdings
25
Report Date
Q1 2023
Filing Type
13F-HR
All Holdings (25 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | VRDNVIRIDIAN THERAPEUTICS INC | 2,699,865 | $68.7M | 0.00% | |
| 2 | COGTCOGENT BIOSCIENCES INC | 4,884,977 | $52.7M | 0.00% | |
| 3 | ELVNENLIVEN THERAPEUTICS INC | 2,214,142 | $48.5M | 0.00% | |
| 4 | TERNTERNS PHARMACEUTICALS INC | 3,619,522 | $42.9M | 0.00% | |
| 5 | PLRXPLIANT THERAPEUTICS INC | 1,430,000 | $38.0M | 0.00% | |
| 6 | —AMBRX BIOPHARMA INC | 3,298,577 | $29.4M | 0.00% | |
| 7 | GHRSGH RESEARCH PLC | 3,517,125 | $28.1M | 0.00% | |
| 8 | —DICE THERAPEUTICS INC | 819,000 | $23.5M | 0.00% | |
| 9 | KALVKALVISTA PHARMACEUTICALS INC | 2,916,667 | $22.9M | 0.00% | |
| 10 | MRUSMERUS N V | 1,226,214 | $22.6M | 0.00% | |
| 11 | CELCCELCUITY INC | 2,105,386 | $21.6M | 0.00% | |
| 12 | AVTEAEROVATE THERAPEUTICS INC | 833,927 | $16.8M | 0.00% | |
| 13 | CABACABALETTA BIO INC | 1,973,251 | $16.3M | 0.00% | |
| 14 | —VECTIVBIO HLDG AG | 1,866,000 | $15.9M | 0.00% | |
| 15 | ANNXANNEXON INC | 3,220,050 | $12.4M | 0.00% | |
| 16 | YB4PSAVARA INC | 6,351,531 | $12.4M | 0.00% | |
| 17 | MISTMILESTONE PHARMACEUTICALS IN | 2,208,812 | $8.7M | 0.00% | |
| 18 | ACRSACLARIS THERAPEUTICS INC | 1,040,754 | $8.4M | 0.00% | |
| 19 | —THESEUS PHARMACEUTICALS INC | 770,000 | $6.8M | 0.00% | |
| 20 | TRVITREVI THERAPEUTICS INC | 3,050,022 | $5.6M | 0.00% | |
| 21 | FULCFULCRUM THERAPEUTICS INC | 1,307,094 | $3.7M | 0.00% | |
| 22 | LYRALYRA THERAPEUTICS INC | 924,170 | $1.9M | 0.00% | |
| 23 | —AVALO THERAPEUTICS INC | 1,000,000 | $1.8M | 0.00% | |
| 24 | RLYBRALLYBIO CORP | 268,532 | $1.5M | 0.00% | |
| 25 | —AFFIMED N V | 1,428,571 | $1.1M | 0.00% |